Foghorn Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GOTTSCHALK ADRIAN | Chief Executive Officer | Gift | 300,000 | — | — | 511,704 | Apr 25, 2025 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Gift | 197,906 | — | — | 511,704 | Apr 9, 2025 |
| Costa Carlos | Chief People Officer | Sale | 857 | $10.17 | $8,716 | — | Sep 23, 2024 |
| Costa Carlos | Chief People Officer | Sale | 11,574 | $10.05 | $116,319 | — | Sep 18, 2024 |
| Costa Carlos | Chief People Officer | Sale | 10,272 | $10.04 | $103,131 | — | Sep 16, 2024 |
| Bellon Steven F. | Chief Scientific Officer | Sale | 20,000 | $9.50 | $190,000 | 101,957 | Sep 9, 2024 |
| Cavalie Fanny | Chief Strategy/Bus Ops Officer | Sale | 11,000 | $6.56 | $72,160 | 75,992 | Mar 11, 2024 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Gift | 63,000 | — | — | — | Aug 17, 2023 |
| Agresta Samuel | Chief Medical Officer | Sale | 311,297 | $8.25 | $2,568,200 | — | Aug 16, 2023 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Gift | 300,000 | — | — | 448,704 | May 26, 2023 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Option Exercise | 40,000 | $0.54 | $21,600 | 186,479 | Sep 16, 2022 |
| GILL SIMBA | — | Option Exercise | 82,000 | $0.73 | $59,860 | 82,000 | Sep 13, 2022 |
| Bellon Steven F. | Chief Scientific Officer | Option Exercise | 1,858 | $3.72 | $6,912 | 121,957 | Aug 11, 2022 |
| Bellon Steven F. | Chief Scientific Officer | Option Exercise | 3,717 | $3.72 | $13,827 | 120,099 | May 25, 2022 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Gift | 4,371 | — | — | 63,000 | Feb 10, 2022 |
| KADOCH CIGALL | — | Gift | 333,333 | — | — | 295,000 | Dec 14, 2021 |
| DECICCO CARL | Chief Scientific Officer | Option Exercise | 104,310 | $3.72 | $388,033 | 362,707 | Dec 9, 2021 |
| GOTTSCHALK ADRIAN | Chief Executive Officer | Option Exercise | 23,000 | $0.54 | $12,420 | 446,479 | Aug 20, 2021 |
| Reine Allan | Chief Financial Officer | Option Exercise | 26,892 | $3.72 | $100,038 | 53,784 | Aug 9, 2021 |
| Abu Dhabi Investment Authority | — | Purchase | 150,000 | $16.00 | $2,400,000 | 1,231,081 | Oct 27, 2020 |
| Flagship Ventures Opportunities Fund I General Partner LLC | — | Purchase | 50,000 | $16.00 | $800,000 | 9,330,878 | Oct 27, 2020 |
| GOTTSCHALK ADRIAN | See Remarks | C | 25,225 | — | — | 25,225 | Oct 27, 2020 |
| DECICCO CARL | Chief Scientific Officer | Purchase | 5,500 | $16.00 | $88,000 | 258,397 | Oct 27, 2020 |